| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Director | Stock Option (right to buy) | 8.46K | $28.3K | $3.35 | May 30, 2024 | Direct |
| Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | May 12, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | May 30, 2024 | 1 | $0 | 4/A | Jun 5, 2024 | Director |
| MURA | Mural Oncology plc | May 30, 2024 | 1 | $28.3K | 4 | Jun 3, 2024 | Director |
| MURA | Mural Oncology plc | Dec 14, 2023 | 1 | $0 | 4 | Dec 18, 2023 | Director |
| MURA | Mural Oncology plc | Oct 31, 2023 | 0 | $0 | 3 | Nov 7, 2023 | Director |
| RUBY | Rubius Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| RUBY | Rubius Therapeutics, Inc. | May 12, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |